amikacin has been researched along with Neointima in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fairaq, A; Osman, I; Pichavaram, P; Segar, L; Shawky, NM | 1 |
1 other study(ies) available for amikacin and Neointima
Article | Year |
---|---|
AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
Topics: AMP-Activated Protein Kinases; Animals; Arteries; Cell Line; Cell Proliferation; Humans; Male; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Neointima; Piperidines; Platelet-Derived Growth Factor; Receptors, Adiponectin; Signal Transduction; TOR Serine-Threonine Kinases | 2017 |